Earnings Call Insights: BioCardia (BCDA) Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final data from three clinical trials of CardiAMP cell therapy, with the latest Phase III results presented as a late-breaking clinical trial. He emphasized, "The key takeaway from these new results is in this title. The Cardiac HF echocardiography clinical results......
Earnings Call Insights: BioCardia (BCDA) Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final data from three clinical trials of CardiAMP cell therapy, with the latest Phase III results presented as a late-breaking clinical trial. He emphasized, "The key takeaway from these new results is in this title. The Cardiac HF echocardiography clinical results... show reductions in left ventricular volume disease when the heart ventricle is fully dilated with a p-value of 0.06 and when the heart is fully contracted with a p-value of 0.09." For the prespecified subgroups of patients with elevated biomarkers of heart stress, he noted differences were clinically meaningful and statistically significant. Altman stated, "We expect to soon submit the Q-sub request on approvability of the CardiAMP system to FDA Center for Biologics Evaluation and Research, or CBER, based on the safety and compelling signals of patients benefits with elevated biomarkers of heart stress from our 3 clinical trials." He also outlined four catalysts for the next quarter: the FDA CardiAMP Heart Failure Q-submission, a formal clinical consultation with Japan PMDA, an FDA feedback meeting on the Helix system, and an abstract presentation at EuroPCR in May. David McClung, CFO, stated, "Total expense accretes approximately 3% year-over-year to $8.3 million in 2025 and compared to $8.1 million in 2024. The primary driver of this change, research and development expense, increased to $5 million in 2025 compared to $4.4 million in 2024." McClung added, "Net loss increased modestly to $8.2 million in 2025 from $7.9 million in 2024. Net cash used in operations was approximately $7.5 million during the year into 2025. That's down from $7.9 million in 2024. The company ended the year with cash and cash equivalents totaling $2.5 million, very comparable to the $2.4 million as of December 31, 2024." Outlook Management expects to "soon submit the Q-sub request on approvabili...
There's a lot in Meta Platforms ' (NASDAQ: META) recent financial updates for the bulls to like. The social media giant is generating incredible top-line momentum. In addition, management guided for even faster growth in Q1. But here's the issue: Meta's artificial intelligence (AI) growth initiatives are slowing its earnings growth. And it seems to be worrying investors. The stock is down about 10...
There's a lot in Meta Platforms ' (NASDAQ: META) recent financial updates for the bulls to like. The social media giant is generating incredible top-line momentum. In addition, management guided for even faster growth in Q1. But here's the issue: Meta's artificial intelligence (AI) growth initiatives are slowing its earnings growth. And it seems to be worrying investors. The stock is down about 10% year to date. Could the stock go even lower this year? Given the staggering shift in the company's cost structure, possibly. Here is a closer look at why the stock's recent pullback might just be the beginning. Image source: Getty Images. Continue reading
MTStock Studio/E+ via Getty Images By Jennifer Nash Fifth district manufacturing activity was flat in March, according to the most recent survey from the Federal Reserve Bank of Richmond. The composite manufacturing index rose ten points to 0, marking the first nonnegative reading in over a year. This month's reading was above the forecast of -8. Here is an excerpt from the latest Richmond Fed man...
MTStock Studio/E+ via Getty Images By Jennifer Nash Fifth district manufacturing activity was flat in March, according to the most recent survey from the Federal Reserve Bank of Richmond. The composite manufacturing index rose ten points to 0, marking the first nonnegative reading in over a year. This month's reading was above the forecast of -8. Here is an excerpt from the latest Richmond Fed manufacturing report : All three of its component indexes rose in March. Shipments increased to −2 from −13, new orders improved to 4 from −9, and employment rose to −2 from −7. The local business conditions index increased to −5 in March from −15 in February. Meanwhile, the future local business conditions index decreased but remained in positive territory. The future indexes for shipments and new orders also decreased slightly but remained solidly in positive territory. The expectations index for employment rose to 14 from 6.The average growth rate of prices paid decreased somewhat, while average growth in prices received increased in March. Firms expected growth in both price measures to moderate over the next 12 months. Background on Richmond Fed Manufacturing The complete data series behind today's Richmond Fed manufacturing report, which dates from November 1993, is available here . The Richmond Manufacturing Index is a gauge of manufacturing activity in the Fifth Federal Reserve District (Maryland, North Carolina, the District of Columbia, Virginia, most of West Virginia, and South Carolina) compiled from a survey of ~100 manufacturers. The composite manufacturing index is an average of indexes on shipments, new orders, order backlogs, capacity utilization, supplier lead times, number of employees, average workweek, wages, inventories, and capital expenditures. This is a diffusion index, meaning negative readings indicate contraction and worsening conditions, while positive ones indicate expansion and improving conditions. The survey offers clues on inflationary pressur...
Indonesia’s markets are likely to grapple with fluctuating sentiment when they reopen Wednesday after a week-long holiday, as investors weigh rapidly shifting headlines on the Iran war and persistent concerns over fiscal and governance risks. A US-listed exchange-traded fund tracking Indonesia’s stocks has slid about 2% since markets closed for Lebaran, the holiday marking the end of Ramadan. An A...
Indonesia’s markets are likely to grapple with fluctuating sentiment when they reopen Wednesday after a week-long holiday, as investors weigh rapidly shifting headlines on the Iran war and persistent concerns over fiscal and governance risks. A US-listed exchange-traded fund tracking Indonesia’s stocks has slid about 2% since markets closed for Lebaran, the holiday marking the end of Ramadan. An Asean stock gauge fell 1.8% during the break. Offshore rupiah forwards rose only about 0.3% higher despite the central bank’s intervention late last week to stem currency weakness, underscoring investors’ reluctance to price in relief. The moves suggest Indonesia’s cash markets will likely fluctuate amid Iran-war tensions, as President Donald Trump signals progress in Iran war negotiations even while deploying more troops to the Middle East. Elevated oil prices are adding to concerns after global ratings agencies cut the country’s credit rating outlook and MSCI Inc. warned of a potential downgrade of its market status pending reforms to improve liquidity. Oil prices have largely held firm, though they slipped Wednesday after Trump said Iran had offered a “present” as a show of good faith in negotiations. Inflation risks from elevated oil prices “complicate the policy backdrop, potentially raising the hurdle for regulators to push through proposed capital market reforms,” said Gary Tan , portfolio manager at Allspring Global Investments in Singapore. Before the holiday, the Jakarta Composite Index was the world’s worst performer this year, sliding more than 20% from its January peak into bear market territory amid concerns over earnings and economic growth. The rupiah and Indonesian bonds have also come under pressure. The currency weakened past levels seen during the Asian Financial Crisis to hit a record low after the credit rating agencies flagged eroding fiscal and policy credibility. Investor sentiment worsened after a government official acknowledged it’d be difficult t...